ATE253040T1 - (2s)-aminoindanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als selektive dopamin-d3-liganden - Google Patents
(2s)-aminoindanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als selektive dopamin-d3-ligandenInfo
- Publication number
- ATE253040T1 ATE253040T1 AT01906556T AT01906556T ATE253040T1 AT E253040 T1 ATE253040 T1 AT E253040T1 AT 01906556 T AT01906556 T AT 01906556T AT 01906556 T AT01906556 T AT 01906556T AT E253040 T1 ATE253040 T1 AT E253040T1
- Authority
- AT
- Austria
- Prior art keywords
- aminoindanderivates
- ligands
- production
- selective dopamine
- dopamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18402000P | 2000-02-22 | 2000-02-22 | |
PCT/US2001/001231 WO2001062712A1 (en) | 2000-02-22 | 2001-02-14 | (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE253040T1 true ATE253040T1 (de) | 2003-11-15 |
Family
ID=22675272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01906556T ATE253040T1 (de) | 2000-02-22 | 2001-02-14 | (2s)-aminoindanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als selektive dopamin-d3-liganden |
Country Status (13)
Country | Link |
---|---|
US (2) | US6410787B2 (de) |
EP (1) | EP1257527B1 (de) |
JP (1) | JP2003523991A (de) |
AR (1) | AR030552A1 (de) |
AT (1) | ATE253040T1 (de) |
AU (1) | AU2001234453A1 (de) |
CO (1) | CO5270005A1 (de) |
DE (1) | DE60101091T2 (de) |
DK (1) | DK1257527T3 (de) |
ES (1) | ES2210128T3 (de) |
PT (1) | PT1257527E (de) |
TR (1) | TR200302026T4 (de) |
WO (1) | WO2001062712A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2708820C (en) * | 2007-12-24 | 2016-05-10 | Cipla Limited | Process for the synthesis of propargylated aminoindan derivatives |
JP5295613B2 (ja) * | 2008-04-07 | 2013-09-18 | 日宝化学株式会社 | ヨウ素化芳香族化合物の製造方法 |
CN102584801B (zh) * | 2011-01-06 | 2015-02-18 | 中国科学院上海有机化学研究所 | Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺 |
CN104418775B (zh) * | 2013-09-05 | 2017-01-18 | 中国科学院大连化学物理研究所 | 一种钯催化氨基醇的不对称氢解合成手性胺的方法 |
CN107056630B (zh) * | 2017-01-23 | 2020-01-17 | 合肥工业大学 | 一种茚满类衍生物及其合成方法和在医药上的用途 |
CN113401961B (zh) * | 2021-05-20 | 2023-06-23 | 陈鹏 | 一种可光谱调控的水处理用黑色素材料及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2139750T3 (es) * | 1993-08-06 | 2000-02-16 | Upjohn Co | 2-aminoindanos como ligandos selectivos d3 de la dopamina. |
CN1159292C (zh) * | 1996-05-31 | 2004-07-28 | 法玛西雅厄普约翰美国公司 | 用作选择性多巴胺d3配体的芳基取代的环胺类化合物 |
-
2001
- 2001-02-14 JP JP2001561722A patent/JP2003523991A/ja active Pending
- 2001-02-14 ES ES01906556T patent/ES2210128T3/es not_active Expired - Lifetime
- 2001-02-14 DK DK01906556T patent/DK1257527T3/da active
- 2001-02-14 EP EP01906556A patent/EP1257527B1/de not_active Expired - Lifetime
- 2001-02-14 PT PT01906556T patent/PT1257527E/pt unknown
- 2001-02-14 AT AT01906556T patent/ATE253040T1/de not_active IP Right Cessation
- 2001-02-14 DE DE60101091T patent/DE60101091T2/de not_active Expired - Fee Related
- 2001-02-14 AU AU2001234453A patent/AU2001234453A1/en not_active Abandoned
- 2001-02-14 US US09/783,649 patent/US6410787B2/en not_active Expired - Fee Related
- 2001-02-14 WO PCT/US2001/001231 patent/WO2001062712A1/en active IP Right Grant
- 2001-02-14 TR TR2003/02026T patent/TR200302026T4/xx unknown
- 2001-02-21 CO CO01013784A patent/CO5270005A1/es not_active Application Discontinuation
- 2001-02-22 AR ARP010100807A patent/AR030552A1/es active IP Right Grant
-
2002
- 2002-04-29 US US10/134,194 patent/US6870070B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AR030552A1 (es) | 2003-08-27 |
US6410787B2 (en) | 2002-06-25 |
ES2210128T3 (es) | 2004-07-01 |
WO2001062712A1 (en) | 2001-08-30 |
AU2001234453A1 (en) | 2001-09-03 |
DK1257527T3 (da) | 2004-01-12 |
EP1257527A1 (de) | 2002-11-20 |
US6870070B2 (en) | 2005-03-22 |
CO5270005A1 (es) | 2003-04-30 |
PT1257527E (pt) | 2004-03-31 |
US20020151596A1 (en) | 2002-10-17 |
DE60101091T2 (de) | 2004-07-29 |
DE60101091D1 (de) | 2003-12-04 |
JP2003523991A (ja) | 2003-08-12 |
TR200302026T4 (tr) | 2004-01-21 |
EP1257527B1 (de) | 2003-10-29 |
US20010044471A1 (en) | 2001-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE347890T1 (de) | Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren | |
DE502004011957D1 (de) | Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE60020163D1 (de) | Fotomaske, verfahren zu ihrer herstellung | |
ATE355277T1 (de) | Chinolin- und isochinolin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer | |
DE502005009723D1 (de) | Arylsubstituierte heterozyklen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE60004382D1 (de) | Zeolithische adsorbentien,verfahren zu ihrer herstellung und ihre verwendung zum entfernen von co2 aus gasströmen | |
DE50312261D1 (de) | Heterozyklisch substituierte benzoylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE60233058D1 (de) | Silsesquioxanderivate und verfahren zu ihrer herstellung | |
DE60313602D1 (de) | N-iPHENYL(PIPERIDIN-2-YL)METHYLöBENZAMIDDERIVATE,VERFAHREN ZU IHRER HERSTELLUNG UND IHRE THERAPEUTISCHE ANWENDUNG | |
ATE348609T1 (de) | Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer | |
DE50207011D1 (de) | Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel | |
DE50110902D1 (de) | Farb- und/oder effektgebende mehrschichtlackierung, verfahren zu ihrer herstellung und ihre verwendung | |
ATE272634T1 (de) | Benzothiophenderivate, verhahren zu ihrer herstellung und ihre verwendung | |
DE50213372D1 (de) | Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament | |
DE50011818D1 (de) | Hochkratzfeste mehrschichtlackierung, verfahren zu ihrer herstellung und ihre verwendung | |
ATE210638T1 (de) | Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
ATE283842T1 (de) | Substituierte benzoylketone, verfahren zu ihrer herstellung und ihre verwendung als herbizide | |
DE50305655D1 (de) | Piezoaktor und ein verfahren zu dessen herstellung | |
DE59912402D1 (de) | Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE253040T1 (de) | (2s)-aminoindanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als selektive dopamin-d3-liganden | |
ATE222584T1 (de) | Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
DE69922378D1 (de) | Oxidierte sulfurierte distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel | |
DE60204015D1 (de) | Piperidincarboxamid-derivate, ein verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen | |
ATE313556T1 (de) | Memno-peptide, verfahren zu ihrer herstellung und ihre verwendung | |
ATE288442T1 (de) | Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1257527 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |